Status:

COMPLETED

Oral Cell DNA Adducts in Smokers

Lead Sponsor:

University of Minnesota

Collaborating Sponsors:

University of Hawaii

Conditions:

Lung Cancer

Eligibility:

All Genders

18+ years

Brief Summary

DNA adducts in the oral mucosa cells of 100 smokers from 3 ethnic groups - Native Hawaiians, Whites, and Japanese Americans with differing risks for lung cancer upon cigarette smoking will be quantifi...

Detailed Description

Using high resolution mass spectrometry, quantify known DNA adducts in oral mucosa cells of 100 smokers from each ethnic group - Native Hawaiians, Whites, and Japanese Americans. DNA adducts of tobacc...

Eligibility Criteria

Inclusion

  • currently smoke at least 5 cigarettes per day, self-identified Japanese Americans, European Americans, or Native Hawaiians.

Exclusion

  • no current use of other nicotine containing products, no acute or uncontrolled medical or psychiatric conditions, no greater than 14 alcoholic drinks per week, not pregnant, not breastfeeding, not currently taking any medications that affect relevant metabolic enzymes, no active infection.

Key Trial Info

Start Date :

February 1 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2021

Estimated Enrollment :

281 Patients enrolled

Trial Details

Trial ID

NCT03285893

Start Date

February 1 2018

End Date

August 1 2021

Last Update

November 12 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Tobacco Use Research Center

Minneapolis, Minnesota, United States, 55455

Oral Cell DNA Adducts in Smokers | DecenTrialz